Key points are not available for this paper at this time.
MS can be the first choice for EBD in patients undergoing NACRT for pancreatic head cancer. MS may be less costly overall.
Share your take
Add a clinician perspective alongside expert commentary.
Kobayashi et al. (2021) studied this question.